Abstract
Supplemental oxygen for patients with idiopathic pulmonary fibrosis (IPF) who experience rest, nocturnal, or exertional desaturation can improve symptoms and quality of life. However, there is no data to show that supplemental oxygen improves survival, although it can improve exercise capacity [1, 2]. Towards the late stages of IPF, high-flow oxygen devices such as an oxymizer or high humidity high-flow nasal cannula may be needed to maintain adequate oxygen saturations and ameliorate symptoms. Oxymizers provide a reservoir of oxygen to draw from on inhalation, which increases the net oxygen concentration delivered to the patient for a given liter flow. High-flow nasal cannulas allow the clinician to control the liter flow (typically 30–50 L/min) and percentage FiO2, allowing for very high concentrations of oxygen to be delivered by a comfortable interface. Figure 8.1 shows a variety of available devices to provide higher level flow oxygen for patients with high oxygen requirements.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J. 2005;25:96–103.
Morrison DA, Stovall JR. Increased exercise capacity in hypoxemic patients after long-term oxygen therapy. Chest. 1992;102:542–50.
Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest. 2011;139:609–16.
Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med. 2008;102:1675–80.
Jastrzebski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006;57 Suppl 4:139–48.
Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13:394–9.
Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax. 2008;63:549–54.
Ferreira A, Garvey C, Connors GL, et al. Pulmonary rehabilitation in interstitial lung disease: benefits and predictors of response. Chest. 2009;135:442–7.
Ozalevli S, Karaali HK, Ilgin D, Ucan ES. Effect of home-based pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Multidiscip Respir Med. 2010;5:31–7.
Rammaert B, Leroy S, Cavestri B, Wallaert B, Grosbois JM. Home-based pulmonary rehabilitation in idiopathic pulmonary fibrosis. Rev Mal Respir. 2011;28:e52–7.
Kozu R, Senjyu H, Jenkins SC, Mukae H, Sakamoto N, Kohno S. Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration. 2011;81:196–205.
Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2011;16:1196–202.
Swigris JJ, Fairclough DL, Morrison M, et al. Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care. 2011;56:783–9.
Huppmann P, Sczepanski B, Boensch M, et al. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur Respir J. 2013;42:444–53.
Jackson RM, Gómez-Marín OW, Ramos CF, et al. Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung. 2014;192:367–76.
Vainshelboim B, Oliveira J, Yehoshua L, et al. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration. 2014;88:378–88.
Brown AW, Kaya H, Nathan SD. Lung transplantation in IIP: a review. Respirology. 2015:1–12 [Epub ahead of print].
Weill D, Benden C, Corris PA, et al. A consensus document for the selection of lung transplant candidates: 2014 – an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2015;34:1–15.
Yusen RD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report – 2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1264–77.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Nathan, S.D., Brown, A.W., King, C.S. (2016). Non-pharmacologic Management of Idiopathic Pulmonary Fibrosis. In: Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. Adis, Cham. https://doi.org/10.1007/978-3-319-32794-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-32794-5_8
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-32792-1
Online ISBN: 978-3-319-32794-5
eBook Packages: MedicineMedicine (R0)